BIOMAT Database Logo BIOMAT Database Logo

Endogenous erythropoietin and salt sensitivity of blood pressure in patients with essential hypertension. 1993

S Naomi, and T Umeda, and T Iwaoka, and J Yamauchi, and Y Ideguchi, and Y Fujimoto, and H Tokunaga, and T Sato
Department of Internal Medicine III, Kumamoto University Medical School, Japan.

To investigate a possible involvement of endogenous erythropoietin (EPO) in the salt sensitivity of blood pressure in essential hypertensive (EHT) patients, plasma EPO concentrations were measured during different salt intakes in 14 patients with EHT. All patients were given low salt (34 mmol NaCl/day) and high salt (342 mmol NaCl/day) diet of 7 days each. The plasma EPO concentrations were significantly higher on the high salt diet than those of low salt diet (23.5 +/- 1.9 v 18.7 +/- 1.8 mIU/ml, mean +/- SD, P < .05). The percentage change of plasma EPO concentration with salt loading correlated positively with hematocrit (Ht) at high salt diet (r = -0.62, P < .02) and tended to be correlated with plasma hemoglobin at high salt diet (r = 0.52, P < .10). These results suggest that the secretion of EPO is increased in response to hemodilution caused by the salt loading and the increased EPO concentration in plasma which may contribute to the increase in blood pressure through an expansion of total blood volume due to an enhanced red cell generation in combination with salt and water retentions.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009320 Atrial Natriuretic Factor A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS. ANF,ANP,Atrial Natriuretic Peptide,Atrial Natriuretic Peptides,Atriopeptins,Auriculin,Natriuretic Peptides, Atrial,ANF (1-126),ANF (1-28),ANF (99-126),ANF Precursors,ANP (1-126),ANP (1-28),ANP Prohormone (99-126),ANP-(99-126),Atrial Natriuretic Factor (1-126),Atrial Natriuretic Factor (1-28),Atrial Natriuretic Factor (99-126),Atrial Natriuretic Factor Precursors,Atrial Natriuretic Factor Prohormone,Atrial Natriuretic Peptide (1-126),Atrial Pronatriodilatin,Atriopeptigen,Atriopeptin (1-28),Atriopeptin (99-126),Atriopeptin 126,Atriopeptin Prohormone (1-126),Cardiodilatin (99-126),Cardiodilatin Precursor,Cardionatrin I,Cardionatrin IV,Prepro-ANP,Prepro-CDD-ANF,Prepro-Cardiodilatin-Atrial Natriuretic Factor,Pro-ANF,ProANF,Proatrial Natriuretic Factor,Pronatriodilatin,alpha ANP,alpha-ANP Dimer,alpha-Atrial Natriuretic Peptide,beta-ANP,beta-Atrial Natriuretic Peptide,gamma ANP (99-126),gamma-Atrial Natriuretic Peptide,Natriuretic Peptide, Atrial,Peptide, Atrial Natriuretic,Peptides, Atrial Natriuretic,Prepro ANP,Prepro CDD ANF,Prepro Cardiodilatin Atrial Natriuretic Factor,Pro ANF,alpha ANP Dimer,alpha Atrial Natriuretic Peptide,beta ANP,beta Atrial Natriuretic Peptide,gamma Atrial Natriuretic Peptide
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004921 Erythropoietin Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Naomi, and T Umeda, and T Iwaoka, and J Yamauchi, and Y Ideguchi, and Y Fujimoto, and H Tokunaga, and T Sato
Endogenous erythropoietin correlates with blood pressure in essential hypertension.
March 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation,
S Naomi, and T Umeda, and T Iwaoka, and J Yamauchi, and Y Ideguchi, and Y Fujimoto, and H Tokunaga, and T Sato
Blood pressure sensitivity to salt, calcium metabolism and insulin sensitivity in essential hypertension.
December 1995, Clinical and experimental pharmacology & physiology,
S Naomi, and T Umeda, and T Iwaoka, and J Yamauchi, and Y Ideguchi, and Y Fujimoto, and H Tokunaga, and T Sato
Salt sensitivity of blood pressure in patients with primary hypertension.
January 1990, Journal of cardiovascular pharmacology,
S Naomi, and T Umeda, and T Iwaoka, and J Yamauchi, and Y Ideguchi, and Y Fujimoto, and H Tokunaga, and T Sato
Association between salt sensitivity and blood pressure variability in patients with essential hypertension and predictive value for cardiovascular events.
January 2023, Cardiovascular journal of Africa,
S Naomi, and T Umeda, and T Iwaoka, and J Yamauchi, and Y Ideguchi, and Y Fujimoto, and H Tokunaga, and T Sato
Assessment of salt sensitivity in essential hypertension by 24-h ambulatory blood pressure monitoring.
October 1995, American journal of hypertension,
S Naomi, and T Umeda, and T Iwaoka, and J Yamauchi, and Y Ideguchi, and Y Fujimoto, and H Tokunaga, and T Sato
Dopaminergic modulation of salt sensitivity in patients with essential hypertension.
March 1986, Life sciences,
S Naomi, and T Umeda, and T Iwaoka, and J Yamauchi, and Y Ideguchi, and Y Fujimoto, and H Tokunaga, and T Sato
[Salt sensitivity in essential hypertension].
January 2000, Nihon rinsho. Japanese journal of clinical medicine,
S Naomi, and T Umeda, and T Iwaoka, and J Yamauchi, and Y Ideguchi, and Y Fujimoto, and H Tokunaga, and T Sato
Salt-induced exacerbation of morning surge in blood pressure in patients with essential hypertension.
January 2000, Journal of human hypertension,
S Naomi, and T Umeda, and T Iwaoka, and J Yamauchi, and Y Ideguchi, and Y Fujimoto, and H Tokunaga, and T Sato
Metabolomics study of blood pressure salt-sensitivity and hypertension.
July 2022, Nutrition, metabolism, and cardiovascular diseases : NMCD,
S Naomi, and T Umeda, and T Iwaoka, and J Yamauchi, and Y Ideguchi, and Y Fujimoto, and H Tokunaga, and T Sato
The essential challenges of salt-sensitivity of blood pressure.
February 2021, Journal of molecular and cellular cardiology,
Copied contents to your clipboard!